Accessory Pathway Clinical Trial
Official title:
Studying New Criteria for Prediction of Site of Accessory Pathway From Surface ECG
Verified date | March 2019 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
study for discovering new criteria for localization of site of accessory pathway from surface ECG
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | August 2021 |
Est. primary completion date | April 2021 |
Accepts healthy volunteers | |
Gender | All |
Age group | 10 Years to 90 Years |
Eligibility |
Inclusion Criteria: - any patient with manifest accessory pathway . Exclusion Criteria: - multiple accessory pathways .previous ablation. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | percise localization of accessory pathway from surface ECG in referance to successful ablation site | successful localization of accessory pathway from surface ECG in referance to successful ablation site during EP maping | 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04361006 -
Cryotherapy Versus Radiofrequency Ablation for Treatment of Para-hisian Accessory Pathways
|
N/A |